Over the last decade animal models have been used extensively to investigate disease processes and therapy for Helicobacter pylori infections. The H. pylori animal models which have been used in pathogenesis and vaccine studies include the gnotobiotic pig, non-human primates, cats, dogs, and several species of rodents including mice, rats, gerbils and guinea pigs. H. felis infection of mice and H. mustelae infection of ferrets have also been used. Recently, investigators have begun using transgenic mice and gene-targeted`knock-out' mice to investigate Helicobacter infections. Each of these animal models has distinct advantages and disadvantages which are discussed in this minireview. The choice of an animal model is dictated by factors such as cost and an understanding of how each model will or will not allow fulfillment of experimental objectives. ß 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
Introduction
Helicobacter animal models have been used to examine (1) antimicrobial therapies, (2) the oncogenic potential of Helicobacter infections, (3) Helicobacter virulence factors, (4) host responses to Helicobacter infections and (5) Helicobacter vaccine development. This minireview will focus on gastric Helicobacters which can be propagated in culture and which have been used to study host responses and vaccine development. For a more extensive discussion of other Helicobacter species and their use in both host responses and non-immunologic research, the reader is referred to the excellent recent reviews by Fox and Lee [1] and by Eaton [2] .
For purposes of this minireview Helicobacter animal models can be subdivided into H. pylori animal models and animal models utilizing other gastric Helicobacters (Table 1) . Of the H. pylori animal models, non-human primate models are ultimately the most similar to humans but are also the most expensive animal models and are also beset with ethical and endangered species issues. The use of nonhuman primate H. pylori models is also discussed elsewhere in this volume by Dubois.
H. pylori animal models

Gnotobiotic pigs
Perhaps the ¢rst H. pylori animal model to be described was the gnotobiotic piglet. This animal model has been extremely useful in helping to demonstrate that putative H. pylori virulence factors such as urease and motility are required for productive infection [3, 4] . Although barrier-born pigs have also been infected with H. pylori and germ-free piglets can be conventionalized after infection, utilization of this model does require a specialized facility where the piglets can either be derived by cesarean section or, at a minimum, be delivered and maintained under barrier conditions. In addition, while infected piglets have been followed for up to 120 days, they grow quite rapidly and it becomes impractical to continue to house them much beyond 60 days. The character of in£ammation induced after infection of piglets di¡ers from human infection in that while lymphocytes/plasma cells are present in both, in contrast to adult humans, infected piglets generally exhibit few neutrophils. In this sense, the H. pylori-infected piglet might be a good model for H. pylori-infected pediatric patients who also exhibit few neutrophils. Both gross and microscopic ulcers have also been reported in infected piglets, adding further credence to this model [5] . One published vaccine study with H. pylori and piglets utilized either oral immunization in the absence of an adjuvant or parenteral immunization and reported only modest reductions in bacterial load but increased pathology (including neutrophils) in immunized, challenged piglets [6] . Despite the fact that the H. pylori infection of piglets is a relatively good disease model, it has not been widely used in immunology/vaccine studies, probably in part due to its cost and the need for specialized facilities.
Dogs and cats
A single report of H. pylori infection of gnotobiotic beagle dog pups has been published [7] . Although the pathology observed in infected pups closely reproduced human pathology, the bacterial load appeared to be low and no overt disease or symptoms were noted. The H. pylori dog model has not been used in immunology or vaccine studies. Natural or experimental H. pylori infection of domestic cats has also been reported [8, 9] . Infected cats developed a lymphofollicular gastritis with small to moderate numbers of eosinophils and (rarely) a moderate antral in¢ltration of neutrophils. It has been suggested that domestic cats might serve as a reservoir for H. pylori infection of humans, but this is unlikely. The initial description of the cat H. pylori infection was from a closed colony of speci¢c pathogen-free animals and it seems more likely that the infection was transmitted to these cats from a human animal caretaker than the other way round. A single small cat vaccination study has been published. In this study, a 20-fold reduction in bacterial density was reported for immunized and challenged cats when compared to non-immune animals [10] . Thus, the H. pylori cat model may be used more widely in the future to study the immune response to Helicobacter infections. However, the widespread prevalence of spiral bacteria (see for example, H. felis below) in the gastrointestinal tracts of domestic cats limits the usefulness of this model to speci¢c pathogen-free, purpose-bred cats which can be quite expensive. In addition, experimental H. pylori infection of cats in our laboratory (unpublished) has yielded only low-grade infections with very mild in£ammation. Thus the infection and disease processes of H. pylori infection of cats need further veri¢cation by additional laboratories.
Gerbils and guinea pigs
Several recent reports have indicated that Mongo- . Using the gerbil model, H. pylori has also been shown to enhance chemical gastric carcinogenesis [14] . As of this writing, no host response or vaccine studies have been published using the gerbil model, although the excellent disease mimics to human infections make it an attractive candidate. The relative lack of immunologic reagents for the gerbil, compared to those available for mice and rats, may hamper progress with this model, however. H. pylori infection of guinea pigs has also recently been reported [15] . The guinea pig model used the mouseadapted Sydney strain of H. pylori (see below) and mild to moderate multifocal antral gastritis was reported. Similar to humans, the dietary requirement of guinea pigs for the antioxidant vitamin C may make this model an especially useful one to study the role of H. pylori in gastric carcinogenesis. Similar to the gerbil, however, a relative lack of immunologic reagents may limit the usefulness of this model for host response and vaccine studies.
H. pylori mouse models
In the late 1980s and early 1990s many laboratories unsuccessfully attempted to establish mouse models of H. pylori infection. In 1991 Karita and colleagues reported that T lymphocyte-de¢cient nude mice could be productively infected with H. pylori but that under identical conditions only a transient infection was established in immunocompetent mice [16] . Although nude mice are not very useful to study immune responses, this result paved the way for other investigators and over the past 3 years many laboratories have reported H. pylori infection in immunocompetent mice [17^22]. Successful mouse models for H. pylori infection would be ideal for the study of host immune responses as a large variety of immunologic reagents are available for the mouse. In addition, mice are relatively cheap, and literally thousands of inbred strains of mice as well as transgenic and knock-out animals (see below) are available. The biggest downside to the mouse models which have been described to date are the low degree of in£ammation and lack of other disease processes observed. There have been some suggestions that selected inbred strains of mice may experience more severe H. pylori disease than other inbred strains of mice [21, 22] , but this has not been a universal ¢nding and disease severity appears much lower than with the mouse H. felis model (see below). In addition, not all H. pylori isolates will infect mice. There appear to be unde¢ned selections or adaptations of H. pylori isolates for growth in the mouse stomach and this could a¡ect the disease (or lack thereof) observed in infected animals. While it has been suggested that the presence of the cag pathogenicity island may be required for H. pylori infection of mice, murine infection with CagA/VacA-negative strains of H. pylori has been reported [19] . The relative lack of disease in H. pylori-infected mice makes this model a poor one to study H. pylori-associated disease. However, the mouse H. pylori models are beginning to be used extensively in vaccine studies where the endpoint is the presence or absence of infection rather than disease.
Other gastric Helicobacter infections used in host response and vaccine studies
In addition to H. pylori, up to two dozen other Helicobacter species which infect other animals, many of which also infect gastric tissue, have been described [1] . Two of these non-H. pylori gastric Helicobacters which have been extensively used to study pathogenesis and vaccine development are H. felis, which was originally isolated from cats and has been used to experimentally infect mice, and H. mustelae, which naturally infects ferrets.
H. felis infection of mice
In 1990, before the successful development of H. pylori mouse models of infection, Adrian Lee and colleagues reported that germ-free mice could be infected with H. felis [23] . It was subsequently shown that H. felis could also infect conventional mice and that the severity of disease varied greatly with the inbred strain of mouse infected. Thus, H. felis-infected C57BL/6 mice were shown to develop severe gastritis and atrophy which includes replacement of parietal cells by mucus-secreting cells, while BALB/c mice infected under identical conditions developed only mild disease [21, 24] . The H. felis mouse model was also used in the ¢rst successful Helicobacter vac-cine studies, before the development of H. pylori mouse models [25, 26] , and it continues to be used in vaccine studies. In spite of the fact that H. felis infection yields more severe disease than H. pylori infection of mice does, H. felis apparently does not contain the cag pathogenicity island, nor does it adhere tightly to gastric epithelial cells. Since both of these traits are accepted virulence factors for H. pylori, the ultimate usefulness of the H. felis mouse model to study H. pylori pathogenesis may be questionable.
H. mustelae infection of ferrets
Virtually all of the commercial colonies of ferrets in the USA and many colonies elsewhere in the world are naturally infected with H. mustelae. This gastric Helicobacter has been associated with an antral predominant lymphocytic (`chronic') gastritis and peptic ulcers as well as MALT lymphomas in the ferret. It has also been reported that H. mustelae possesses a cagA gene [27] , which in H. pylori is a marker for the cag pathogenicity island. Similar to H. pylori infection of gnotobiotic pigs, the ferret and H. mustelae have been used extensively to study bacterial virulence factors. A small number of host response and vaccine studies have been done in this model. Two research groups showed that antimicrobial cure of a natural H. mustelae infection does not result in immunity to reinfection [28, 29] . Thus successful Helicobacter vaccination appears to result in immune responses which are qualitatively di¡erent from that induced as a result of infection. In another study in ferrets, an oral vaccine trial using an ineffective mucosal adjuvant was unsuccessful and actually resulted in worse disease including ulcers in infant ferrets [30] . Finally, we have shown that oral therapeutic vaccination of ferrets can clear H. mustelae from about 30% of these naturally infected animals and can dramatically reduce the severity of disease in the remaining animals [31] . This result with naturally infected animals is a much more rigorous test of the concept of therapeutic immunization than is clearance of H. felis infection from experimentally infected mice.
One advantage which H. mustelae-infected ferrets as well as H. pylori-infected dogs and cats (see above) and other relatively large animals have over smaller rodents is that they can be repeatedly endoscoped to follow infection status and to retrieve biopsies for histologic analysis. The major shortcoming to the use of the ferret in immunologic studies at present is the paucity of reagents. If and when additional reagents become available the ferret H. mustelae model should be an extremely useful one for the study of host response and vaccine development.
Using inbred, transgenic and knock-out mice to study Helicobacter infections
Although mouse H. pylori and H. felis models are limited by their poor disease mimic of human disease and lack of bacterial virulence factors, respectively, there is such a wealth of inbred, mutant and specially created strains of mice available, that mouse Helicobacter models will likely continue to receive much attention in the future. In the following paragraphs, examples will be cited from the literature to illustrate the kinds of studies which can be accomplished using these mouse strains. It is not the purpose of this minireview to completely summarize the state of the art of vaccine development or host responses towards Helicobacter infections but rather to point out what kinds of studies are possible using these mouse strains. One possible explanation for the low level of pathology observed using most mouse H. pylori models is the lack of adherence of H. pylori to mouse tissues. This is one of many areas which it may be possible to study using genetically engineered mice. One putative receptor for H. pylori involves fucose residues on complex human gastric cell surface polysaccharides. A transgenic mouse has been developed which expresses an enzyme which can add fucose to polysaccharides in mouse gastric tissue. Recent results with this transgenic mouse infected with H. pylori have suggested that more severe pathology occurs in the transgenic mouse than in control non-transgenic mice [32] . Additional examples of how the use of inbred and genetically altered mouse strains can advance our knowledge of host responses to Helicobacter infections are included in the sections which follow.
Helicobacter disease severity is related to
variations in host response Much Helicobacter research has focused on viru-lence factors of the bacteria such as urease, VacA and the cag pathogenicity island. As already mentioned above, however, di¡erent inbred strains of mice vary in their in£ammatory/immune responses to identical Helicobacter infections [21, 24] . These studies have primarily used the H. felis model since the in£ammatory response to H. felis is much more robust than the in£ammatory response to H. pylori in the mouse. In addition to the description of these genetic di¡erences, additional mouse strains have been used to try to approach possible mechanisms involved. It has been shown, for example, that whereas lipopolysaccharide (LPS)-responsive C3H/ He mice developed severe atrophy after H. felis infection, the congenic LPS non-responsive C3H/Hej strain exhibited no atrophy. [33] . Further, use of major histocompatibility complex (MHC) congenic mice showed that non-MHC genes appear to play a major role in control of the magnitude of the in£ammatory response to H. felis infection [24] . In a more recent study, H. felis-infected C57BL/6 mice exhibited enhanced apoptosis and fundic epithelial cell proliferation when compared with infected BALB/c or C3H/Hej mice [34] . In this study enhanced apoptosis was correlated with gastric expression of phospholipase A2, a gene product which has recently been associated with formation of polyps in the colon. Finally, the role which interleukin (IL)-10 (an`anti-in£ammatory' T-helper cell type 2 cytokine) plays in the in£ammatory process has been examined using wild -type and IL-10 gene-targeted mice in which the IL-10 gene has been`knocked out'. In this study H. felis-infected IL-10 knock-out mice exhibited a more severe and hyperplastic/atrophic gastritis than did wild-type mice with a functioning IL-10 gene [35] indicating a role for this cytokine in control of the in£ammatory response.
The use of immunode¢cient mice to study
Helicobacter infections The studies summarized above hint that immune responses may contribute to the pathology observed after gastric Helicobacter infections. We have used severe combined immunode¢cient (SCID) mice in our laboratory to more directly examine this question. Wild-type BALB/c mice and BALB/c mice with the SCID mutation infected with H. felis exhibited a low level but equivalent in£ammatory response [36] .
In contrast, C57BL/6 mice, which normally exhibit high in£ammation after H. felis infection, demonstrated a much lower in£ammatory response when mice with the SCID mutation on the C57BL/6 background were infected (Jump, Czinn and Nedrud, unpublished) These results suggest that the immune response makes an important contribution to the gastritis observed after Helicobacter infections. The use of inbred strains of mice where tissues can be freely exchanged among members of the inbred strain has allowed us to con¢rm this hypothesis. We showed that adoptive transfer of spleen cells or T cell lines from H. felis infected immunocompetent C57BL/6 mice into naive recipients exacerbated the gastritis in recipient mice if the recipients were challenged with H. felis [37] .
Elsewhere in the gastrointestinal tract, many strains of immunode¢cient or T cell receptor or cytokine knock-out mice have been demonstrated to be susceptible to in£ammatory bowel disease. The fact that non-gastric Helicobacter organisms may play a role in these models of in£ammatory bowel disease was recently demonstrated when it was shown that either SCID mice or T cell-de¢cient nude rats developed in£ammatory bowel disease when they were infected with H. bilis, an intestinal Helicobacter [38, 39] .
2.8.3. The use of inbred and knock-out mice in vaccine development: mechanisms of protection Based on knowledge from other mucosal pathogens, the initial assumption in Helicobacter vaccine studies was that gastric IgA antibodies probably played a major role in preventing or clearing Helicobacter infections. Although many di¡erent animal models including mice, ferrets, cats and non-human primates have been used in vaccine studies, only recently has the use of several di¡erent types of genetargeted knock-out mice begun to elucidate probable mechanisms of vaccine-induced resistance to infection. The availability of IgA-de¢cient mice allowed our laboratory to conclude that IgA antibodies are, in fact, not required for protection after oral vaccination [40] . We found, however, that potentially compensating levels of IgM antibodies, which can also be transported onto mucosal surfaces, were produced in these IgA knock-out mice. More recently we and our colleagues have used WMT B cell-de¢-cient mice, which produce no antibodies at all, to show that protection from either H. felis or H. pylori can occur in the absence of any antibodies [41, 42] . These results suggested that T cells may play a role in protection from Helicobacter infections in these models and our colleagues showed that mice which are de¢cient in CD4 T cells are indeed not protected from H. pylori infection [42, 43] . Furthermore, we and others have used cytokine knock-out mice to show that the T cell cytokines IL-4 and perhaps interferon-Q as well may be required for protection from Helicobacter infection [44, 45] . As is true for in£ammation, a role for T cells in protection from H. felis has been con¢rmed by adoptive transfer of H. felis speci¢c T cells into naive recipients in inbred mice [37] . Although these results do not demonstrate exactly how T cells or cytokines mediate protective immunity, they do demonstrate the power of using the emerging technology of gene-targeted knock-out animals to answer questions in Helicobacter vaccine development and pathogenesis.
Conclusions
As summarized in this minireview and Table 2 , there is no`best' animal model for gastric H. pylori infections. Rather, each model has strengths and weaknesses and the choice of an animal model depends on experimental objectives. One area which is sure to receive increasing attention in the future, however, is the use of transgenic and knock-out animals. Although it is possible to derive these animals in many species, the large number of transgenic and knock-out mice currently being developed worldwide will place increased emphasis on mouse Helicobacter models. 
